フォローフィードコミュニティでトレーダーや投資家とつながりましょう.
包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.
ターミナル モニターで株式と資産のウォッチリストを整理および監視します
Press release OXFORD BIOMEDICA PLCINTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2024 Delivering Pure-Play...
Oxford Biomedica PLC 23 September 2024 Press release OXFORD BIOMEDICA PLC INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2024 Delivering...
Oxford Biomedica rebrands as OXB reinforcing transformation into leading global cell and gene therapy CDMO...
Lucinda Crabtree joins Oxford Biomedica as Chief Financial Officer today Oxford, UK – 2 September 2024: Oxford...
Oxford Biomedica PLC 02 September 2024 Lucinda Crabtree joins Oxford Biomedica as Chief Financial Officer today Oxford, UK - 2 September...
Oxford Biomedica PLC 02 September 2024 Oxford Biomedica Total Voting Rights Oxford, UK - 02 September 2024: Oxford Biomedica plc (LSE:OXB...
Oxford Biomedica to host a free webinar showcasing its AAV expertise Oxford, UK - 27 August 2024: On Wednesday...
Oxford Biomedica PLC 09 August 2024 Oxford Biomedica Directorship notification under UK Listing Rule 6.4.9 (2) Oxford, UK - 9 August...
SOUTH SAN FRANCISCO, Calif., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS...
Half Year Trading Update and Notice of Interim Results Full year 2024 revenue and medium-term financial...
Oxford Biomedica PLC 08 August 2024 Half Year Trading Update and Notice of Interim Results - Full year 2024 revenue and medium-term...
Oxford Biomedica PLC 01 August 2024 Oxford Biomedica Total Voting Rights Oxford, UK - 01 August 2024: Oxford Biomedica plc (LSE:OXB...
Oxford Biomedica PLC 30 July 2024 Oxford Biomedica Directorship notification under UK Listing Rule 6.4.9 (2) Oxford, UK - 30 July...
Oxford Biomedica PLC 29 July 2024 Oxford Biomedica Directorship notification under UK Listing Rule 6.4.9 (2) Oxford, UK - 29 July...
Oxford Biomedica PLC 25 July 2024 Oxford Biomedica Appoints Laurence Espinasse as Non-Executive Director Oxford, UK - 25 July...
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約